Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
Your comments are welcome:
submit feedback
|
|
Account summary |
|
Search detail for: |
Foley Hoag LLP
|
Registration year: |
2022 |
Registration type:
|
Lobbyist Entity
|
Address:
|
155 Seaport Boulevard Boston, MA, 02210 US / 617-832-1000
|
Lobbyist information
|
Amount
|
Total salaries paid:
$170,000.00
|
|
Client information
|
Amount
|
American Chemistry Council
|
$50,000.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2022
|
|
Areas of Interest: All matters associated with chemical and product
bans as well as environmental regulations. Names of Legislators/
Regulatory Bodies: TURI and associated boards (Science Advisory
Board, Administrative Council), Executive Office of Energy and
Environmental Affairs, MassDEP
|
|
Amgen Inc.
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2022
|
|
Legislation, regulations, and issues related to biopharmaceuticals, health care, drug pricing, transparency, business, and taxation.
|
|
bluebird bio, Inc.
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2022
|
04/25/2022
|
State Medicaid coverage and payment policies for gene therapies
|
|
Gilead Sciences, Inc.
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2022
|
|
Any and all matters relating to Gilead Sciences, Inc. including HIV/AIDS, Hepatitis C, oncology, drug pricing policy, and patient access to health care.
|
|
Massachusetts Biotechnology Council
|
$120,000.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2022
|
|
Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.
|
|
Vertex Pharmaceuticals Incorporated
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2022
|
|
All matter related to Patient access to medicines, medicaid, drug pricing, and drug cost containment.
|
|
Total salaries received:
$170,000.00
|
|
|
* No expense has been disclosed.
|
|
Disclosure Report details
|
|
|
|